A new review published in World Journal of Pediatrics provides a systematic analysis of how CHD family proteins orchestrate gene expression during heart development, revealing that these chromatin remodelers have distinct, stage-specific roles. The study, led by a team from China and available at DOI: 10.1007/s12519-026-01049-y, synthesizes evidence from human genetics, animal models, and stem-cell systems to assign specific cardiac functions to different CHD family members.
The research highlights a clear division of labor among CHD proteins. CHD7, most frequently mutated in CHARGE syndrome, plays a dominant role in early heart structure formation. CHD3 and CHD4 act as "identity guardians" during chamber formation, ensuring correct cell fate. CHD8 regulates later ventricular growth and functional maturation. The authors propose three testable models—parallel, sequential, and compensatory—to guide future research on how these proteins coordinate across development.
The findings have direct clinical implications. For genetic screening, the study prioritizes CHD7 for outflow-tract defects, CHD4 for chamber-patterning anomalies, and CHD8 for ventricular dysfunction, potentially improving diagnostic efficiency. Therapeutically, while directly targeting remodelers is risky due to their broad expression, identifying downstream pathways—such as those regulating cardiomyocyte proliferation or metabolism—may offer safer drug targets. Future studies combining time-resolved multi-omics and combinatorial genetics could uncover how these proteins coordinate, paving the way for precise, temporally controlled epigenetic therapies.
The review emphasizes that direct proof of coordinated action among CHD proteins is lacking, and the proposed models aim to clarify how these remodelers might cooperate or compensate for each other. This refined framework not only clarifies which gene to prioritize for specific heart defects but also opens new questions about the interplay of these essential regulators across developmental time.
